Tetrahedron Letters
Synthesis of imidazo[1,2-a]pyridine in the presence of iodine–water
catalytic system
⇑
I. R. Siddiqui , Pragati Rai, Rahila, Anushree Srivastava, Shayna Shamim
Laboratory of Green Synthesis, Department of Chemistry, University of Allahabad, Allahabad 211002, India
a r t i c l e i n f o
a b s t r a c t
Article history:
We have devised an expedient, cleaner, and environmentally friendly approach for ‘on water’ mediated
synthesis of imidazo[1,2-a]pyridine derivatives. The synthesis involves in situ formation of imines
followed by addition of alkyne to give the desired products in excellent yield.
Ó 2014 Elsevier Ltd. All rights reserved.
Received 19 October 2013
Revised 20 December 2013
Accepted 24 December 2013
Available online 9 January 2014
Keywords:
Imidazo[1,2-a]pyridine
Iodine
Aqueous medium
Eco-friendly
Multicomponent reaction
The use of multicomponent reactions (MCR) to form several
bonds via single step synthesis and to integrate different fragments
into one molecule has made a big advancement in the field of
chemical research in recent decade.1 Due to increasing concerns
over hazardous effect of organic solvents on environment and hu-
man beings, various types of MCR have been successfully investi-
gated in aqueous medium. Reactions in aqueous environment
have attracted attention due to its unique reactivity and selectivity
that are difficult to achieve in conventional organic solvents.
Water, probably due to its unique abilities such as hydrogen bond-
ing, high dielectric constant, and polarity appears to be a more effi-
cient medium for organic transformation.2,3 In this context water is
preferable solvent and a remarkable contributor in the field of
organic synthesis.
identified as selective cyclin-dependent kinase inhibitors,8 calcium
channel blockers,9 and beta-amyloid formation inhibitors10 and
also constitute orally active non-peptide bradykinin B2 receptor
antagonists.11
All these bioactivities make imidazo[1,2-a]pyridine an interest-
ing scaffold for organic chemists. Numerous methodologies have
been enumerated for the synthesis of imidazo [1,2-a]pyridines by
using transition metal salts and other catalysts.12–16 Among these,
the three-component coupling of aldehyde, 2-aminopyridine, and
alkyne is one of the most preferable method for the synthesis of
imidazo[1,2-a]pyridine.17,18 The disadvantages of all these investi-
gations are requirement of expensive and huge amount of catalyst,
long reaction time, use of metal catalyst which is separated after
complex process, unsatisfactory yield of the product, and harsh
reaction conditions.13 During recent years molecular iodine has re-
ceived considerable interest due to its low price, sustainability,
ready availability, non toxicity, and eco-friendly properties.19 The
use of iodine as Lewis acid has increased substantially due to its
quality of high tolerance to air, moisture, and high catalytic activity
in dilute as well as in highly concentrated condition.20 Recently, it
has been successfully employed to synthesize indoles and oxaz-
oles. Encouraged by these advances, we sought to investigate the
application of this reagent in imidazo[1,2-a]pyridine synthesis.
The considerations described above inspired us to investigate
the three-component conversion of 2-aminopyridine, aldehyde,
and alkyne, in imidazo[1,2-a]pyridine by employing iodine as a
catalyst in aquatic condition (Scheme 1). To the best of our knowl-
edge, this is the first approach for the synthesis of imidazo[1,2-
a]pyridine in water by using molecular iodine.
Over the years, the pharmacological potential of imidazo[1,2-
a]pyridine has attracted extensive interest from both medicinal
and synthetic chemists because of their presence in broad spec-
trum of natural and synthetic organic molecules with diverse bio-
logical properties.
A wide range of compounds possessing
imidazo[1,2-a]pyridine scaffold have been employed as antibacte-
rial, antiviral, anti-inflammatory, antiulcer, immunomodulatory,
and anticonvulsant.4–6 Further imidazo[1,2-a]pyridine also consti-
tutes the core structure of various drugs7 like zolpidem which is
used in the treatment of insomnia, alpidem as an anxiolytic agent,
olprinone for the treatment of acute heart failure, and zolimidine
used for the treatment of peptic ulcer (Fig. 1). They have also been
⇑
Corresponding author. Tel.: +91 9335153359.
0040-4039/$ - see front matter Ó 2014 Elsevier Ltd. All rights reserved.